How Mediclinic’s Integration Strategy Doubled Patient Throughput

Mediclinic Middle East

$18.4B
Total Investment
47
Deals Tracked
12
Countries

When Mediclinic Middle East restructured its four-hospital footprint in 2024, the initial strategy was conventional: consolidate back-office, centralize procurement, harmonize the EHR. Twelve months in, the COO realized the numbers weren’t moving. Patient-flow was the constraint, not overhead.

The intervention

The team rebuilt scheduling from the discharge planner backward. Every admission now arrives with a target discharge date set by a length-of-stay model trained on the group’s own priors — not the vendor’s default distribution. Beds are held only when the data says so.

The result

Throughput doubled in the cardiology and orthopedic services within two quarters. Readmissions didn’t increase. The operational payoff — the part boards care about — shows in the group’s EBITDA walk: a 340 bps margin expansion in FY25, most of it attributable to fixed-cost leverage on higher case volume.